“Informative Censoring in CDK4/6 Inhibitor Adjuvant Therapy for Early Breast Cancer: A Sensitivity Analysis of Invasive Disease-Free Survival in the monarchE Trial” (2025) Epidemiology, Biostatistics, and Public Health [Preprint]. doi:10.54103/2282-0930/29562.